Replies to post #122014 on Avid Bioservices Inc (CDMO)

[jakedogman1]

maybe reg needs to find out about the dose switching scandal

To contact the editor responsible for this story: Reg Gale at [e-mail]

[rome75]

"Dr. Schwartz is a 30-year veteran of the Pharmaceutical Industry most recently in the role of Executive Director, Strategic Transactions for Bristol-Myers Squibb Company where he has more than a dozen completed transactions to his credit. He speaks frequently on the Biotech-Big Pharma dynamics and evolving research and treatment paradigms in oncology and is perhaps best known for predicting FDA’s rejection of Dendreon’s Provenge vaccine in 2007 (San Francisco Chronicle, March 30, 2007). Provenge ultimately won FDA approval in April, 2010.

Dr. Schwartz founded RHS Advisors, LLC, a life-sciences consulting firm, in July 2010.
SNAPSHOT"
Remember this clown bashing peregrine a few months ago with his seeking alpha article. I wonder what he knew about dose switching ?

[biopharm]

Now how does that 1 year+ delay sound when you read something like this? The key point I take was they are not coming to ASCO with results for breast and lung cancer.... Peregrine has the results now and the FDA best have some good news for keeping the lid on the sabotage scandal.

[freethemice]

The person named Michael Gordon quoted in this article is a medical advisor for Peregrine.
http://www.peregrineinc.com/about-us/medical-and-scientific-advisors.html